Rachel Hollen Bublitz, APRN
Clinical Nurse Specialist · Oklahoma City, OKNPI 1659910446
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $483 of the $553 with a category attached, or 87.3%. 13 manufacturers reported payments, led by Daiichi Sankyo Inc. at 42.3% of the total. 2025 is the largest year on record at $404, 4.4 times the $92 reported in 2023. That places this record below the midpoint for clinical nurse specialist clinicians in OK, where the typical reported total is $852.
Across 25 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$234
- Genmab U.S., Inc.$51
- AbbVie$42
- Stemline Therapeutics Inc.$38
- Lilly USA, LLC$31
- Array Biopharma Inc$27
- plus $130 from 7 others
What the payments were for
- Food & beverage$48387%
- Education$7013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $234 |
| Genmab U.S., Inc. | 3 | $51 |
| AbbVie | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| Array Biopharma Inc | 1 | $27 |
| EMD Serono, Inc. | 1 | $26 |
| AstraZeneca | 1 | $20 |
| Novartis | 1 | $18 |
| Sobi, Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Acrotech Biopharma Inc. | 1 | $16 |
| Seagen Inc. | 1 | $16 |
How this compares
$553 in reported general payments places this provider in the 40th percentile of 56 clinical nurse specialist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 25 | $4,887 |
| Naloxone Hcl | 16 | $933 |
| Buprenorphine Hcl | 24 | $746 |
| Tizanidine Hcl | 32 | $463 |
| Gabapentin | 22 | $442 |
| Olanzapine | 27 | $439 |
| Pregabalin | 25 | $333 |
| Mirtazapine | 18 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $31 | $43927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 56 clinical nurse specialist providers in Oklahoma.
Other clinical nurse specialist in Oklahoma City
- Erica MelickOklahoma City$5K
- Kelly Lang-SheppardOklahoma City$5K
- Cheryl WestOklahoma City$4K
- April MerrillOklahoma City$2K
- Danielle ZacharyOklahoma City$2K
- Heather GrahamOklahoma City$2K
- Amy EberleOklahoma City$1K
- Robin MartinOklahoma City$1K
- Michelle PopeOklahoma City$1K
- Linda PitchfordOklahoma City$929
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.